RecruitingNot ApplicableNCT05790356

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial


Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment

30 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether fecal microbiota transplantation (FMT) — transplanting stool from a healthy donor — can help people with rheumatoid arthritis (RA) who are currently in remission or have low disease activity. Researchers believe gut bacteria may play a role in autoimmune diseases like RA and want to test whether changing the gut microbiome can extend remission. **You may be eligible if...** - You are 18 or older with a confirmed diagnosis of rheumatoid arthritis - You test positive for RA antibodies (ACPA and/or rheumatoid factor) - Your RA medications have been stable for more than 6 months - Your disease is currently in remission or at low activity **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have recently (within 60 days) used high-dose steroids, IV steroids, biologic therapies, or JAK inhibitors - You have a diagnosed immune deficiency (HIV, transplant history, or other autoimmune diseases requiring treatment) - You have had a gastrointestinal infection or antibiotic treatment recently Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFecal Microbial transplant

Fecal microbial transplant will be investigated for its effect on gut bacterial composition in patients with rheumatoid arthritis.

OTHERPlacebo capsules

The placebo capsules will not contain FMT but will have the same appearance.


Locations(1)

St. Joseph's Health Care London

London, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05790356


Related Trials